AAAAAA
Results: 1-25/61
Authors:
FERN KT
SMITH JT
ZEE B
LEE A
BORSCHNECK D
PICHORA DR
Citation: Kt. Fern et al., TRAUMA PATIENTS WITH MULTIPLE EXTREMITY INJURIES - RESOURCE UTILIZATION AND LONG-TERM OUTCOME IN RELATION TO INJURY SEVERITY SCORES, The journal of trauma, injury, infection, and critical care, 45(3), 1998, pp. 489-494
Authors:
PATER J
OSOBA D
ZEE B
LOFTERS W
GORE M
DEMPSEY E
PALMER M
CHIN C
Citation: J. Pater et al., EFFECTS OF ALTERING THE TIME OF ADMINISTRATION AND THE TIME FRAME OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - AN EXAMPLE USING THE EORTC QLQ-C30 IN A LARGE ANTIEMETIC TRIAL, Quality of life research, 7(3), 1998, pp. 273-278
Authors:
PATER J
BEZJAK A
OSOBA D
ZEE B
PALMER M
Citation: J. Pater et al., QUALITY-OF-LIFE (QL) AS AN END-POINT IN NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG) STUDIES - HAVE WE LEARNED ANYTHING NEW, Annals of oncology, 9, 1998, pp. 682-682
Authors:
GELMON K
TOMIAK E
TOLCHER T
BLACKSTEIN M
ZEE B
BATIST G
IGLESIAS J
FISHER B
EISENHAUER E
Citation: K. Gelmon et al., RANDOMIZED TRIAL OF HIGH-DOSE PACLITAXEL (TAXOL, T) PLUS MINUS AMIFOSTINE (A) IN METASTATIC BREAST-CANCER (MBC) - A STUDY OF THE NCIC CLINICAL-TRIALS GROUP (CTG)/, Annals of oncology, 9, 1998, pp. 371-371
Authors:
ZEE B
COLE B
LI T
BROWMAN G
JAMES K
JOHNSTON D
SUGANO D
PATER J
Citation: B. Zee et al., QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(8), 1998, pp. 2834-2839
Authors:
HOSKINS P
EISENHAUER E
BEARE S
ROY M
DROUIN P
STUART G
BRYSON P
GRIMSHAW R
CAPSTICK V
ZEE B
Citation: P. Hoskins et al., RANDOMIZED PHASE-II STUDY OF 2 SCHEDULES OF TOPOTECAN IN PREVIOUSLY TREATED PATIENTS WITH OVARIAN-CANCER - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 16(6), 1998, pp. 2233-2237
Authors:
LATREILLE J
PATER J
JOHNSTON D
LABERGE F
STEWART D
RUSTHOVEN J
HOSKINS P
FINDLAY B
MCMURTRIE E
YELLE L
WILLIAMS C
WALDE D
ERNST S
DHALIWAL H
WARR D
SHEPHERD F
MEE D
NISHIMURA L
OSOBA D
ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
Authors:
LEVY E
PIEDBOIS P
BUYSE M
PIGNON JP
ROUGIER P
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
QUINAUX E
THIRION P
RYAN L
HANSEN R
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
PIGNON JP
LAPLANCHE A
LUBOINSKI M
ROUGIER P
BRUFMAN G
ISACSON R
VAITKEVICIUS V
PIEDBOIS P
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
LEVY E
THIRION P
DURANDZALENSKI I
BUYSE M
QUINAUX E
WOLMARK N
PIEDBOIS P
BUYSE M
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: E. Levy et al., TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3537-3541
Authors:
ZEE B
JAMES K
PATER J
Citation: B. Zee et al., CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY, Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
Authors:
OSOBA D
RODRIGUES G
MYLES J
ZEE B
PATER J
Citation: D. Osoba et al., INTERPRETING THE SIGNIFICANCE OF CHANGES IN HEALTH-RELATED QUALITY-OF-LIFE SCORES, Journal of clinical oncology, 16(1), 1998, pp. 139-144
Authors:
WOLMARK N
PIEDBOIS P
ROUGIER P
BUYSE M
PIGNON JP
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
LEVY E
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
LUBOINSKI M
VAITKEVICIUS V
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
DURANDZALESKI I
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
Authors:
CHAN E
PANDITH V
TOWHEED TE
BROUILLARD D
ZEE B
ANASTASSIADES TP
Citation: E. Chan et al., COMPARISON OF THE COMBINED CORTICAL THICKNESS OF THE 2ND METACARPAL WITH SHARPS METHOD FOR SCORING HAND MICRORADIOGRAPHS IN RHEUMATOID-ARTHRITIS, Journal of rheumatology, 25(7), 1998, pp. 1290-1294
Authors:
OSOBA D
ZEE B
Citation: D. Osoba et B. Zee, COMPLETION RATES IN HEALTH-RELATED QUALITY-OF-LIFE ASSESSMENT - APPROACH OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Statistics in medicine, 17(5-7), 1998, pp. 603-612
Authors:
ZEE B
DELUZIO K
SORBIE C
OLNEY S
BRYANT T
Citation: B. Zee et al., CHALLENGES IN ORTHOPEDIC SURGICAL RANDOMIZED TRIALS - DESIGN AND ANALYSIS, Zhongguo yaoli xuebao, 19, 1998, pp. 25-25
Authors:
SHEPHERD FA
JOHNSTON MR
PAYNE D
BURKES R
DESLAURIERS J
CORMIER Y
DEBEDOYA LD
OTTAWAY J
JAMES K
ZEE B
Citation: Fa. Shepherd et al., RANDOMIZED STUDY OF CHEMOTHERAPY AND SURGERY VERSUS RADIOTHERAPY FOR STAGE IIIA NON-SMALL-CELL LUNG-CANCER - A NATIONAL-CANCER-INSTITUTE OFCANADA CLINICAL-TRIALS GROUP-STUDY, British Journal of Cancer, 78(5), 1998, pp. 683-685
Authors:
ANASTASSIADES TP
CHAN E
FENTON P
NAIR P
ZEE B
Citation: Tp. Anastassiades et al., RELIABILITY OF RADIOGRAPHIC SCORING OF DEGENERATIVE CHANGES IN THE LUMBAR SPINE (DCLS), Arthritis and rheumatism, 41(9), 1998, pp. 679-679
Authors:
OSOBA D
AARONSON N
ZEE B
SPRANGERS M
VELDE AT
Citation: D. Osoba et al., MODIFICATION OF THE EORTC QLQ-C30 (VERSION-2.0) BASED ON CONTENT VALIDITY AND RELIABILITY TESTING IN LARGE SAMPLES OF PATIENTS WITH CANCER, Quality of life research, 6(2), 1997, pp. 103-108
Authors:
DANCEY J
ZEE B
OSOBA D
WHITEHEAD M
LU F
KAIZER L
LATREILLE J
PATER JL
Citation: J. Dancey et al., QUALITY-OF-LIFE SCORES - AN INDEPENDENT PROGNOSTIC VARIABLE IN A GENERAL-POPULATION OF CANCER-PATIENTS RECEIVING CHEMOTHERAPY, Quality of life research, 6(2), 1997, pp. 151-158
Authors:
DANCEY J
ZEE B
OSOBA D
WHITEHEAD M
PALMER M
PATER J
Citation: J. Dancey et al., GENDER AND AGE INFLUENCE BASE-LINE QUALITY-OF-LIFE (QL) ASSESSMENTS IN CANCER-PATIENTS, European journal of cancer, 33, 1997, pp. 260-260
Authors:
EISENHAUER E
BACON M
WALSH W
MCDANIEL C
CANETTA R
ONETTO N
ZEE B
Citation: E. Eisenhauer et al., LONG-TERM SURVIVORS FROM A EUROPEAN-CANADIAN TRIAL OF PACLITAXEL IN PLATINUM-PRETREATED OVARIAN-CANCER (OVCA), European journal of cancer, 33, 1997, pp. 532-532
Authors:
PATER JL
ZEE B
PALMER M
JOHNSTON D
OSOBA D
Citation: Jl. Pater et al., FATIGUE IN PATIENTS WITH CANCER - RESULTS WITH NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP STUDIES EMPLOYING THE EORTC QLQ-C30, Supportive care in cancer, 5(5), 1997, pp. 410-413
Authors:
OSOBA D
ZEE B
WARR D
LATREILLE J
KAIZER L
PATER J
Citation: D. Osoba et al., EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE, Supportive care in cancer, 5(4), 1997, pp. 307-313
Authors:
PATER JL
LOFTERS WS
ZEE B
DEMPSEY E
WALDE D
MOQUIN JP
WILSON K
HOSKINS P
GUEVIN RM
VERMA S
NAVARI R
KROOK JE
HAINSWORTH J
PALMER M
CHIN C
Citation: Jl. Pater et al., THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Annals of oncology, 8(2), 1997, pp. 181-185
Authors:
LOFTERS WS
PATER JL
ZEE B
DEMPSEY E
WALDE D
MOQUIN JP
WILSON K
HOSKINS P
GUEVIN RM
VERMAN S
NAVARI R
KROOK JE
HAINSWORTH J
PALMER M
CHIN C
Citation: Ws. Lofters et al., PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 15(8), 1997, pp. 2966-2973
Authors:
PRITCHARD KI
PATERSON AHG
FINE S
PAUL NA
ZEE B
SHEPHERD LE
ABUZAHRA H
RAGAZ J
KNOWLING M
LEVINE MN
VERMA S
PERRAULT D
WALDE PLD
BRAMWELL VHC
POLJICAK M
BOYD N
WARR D
NORRIS BD
BOWMAN D
ARMITAGE GR
WEIZEL H
BUCKMAN RA
Citation: Ki. Pritchard et al., RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY ADDED TO TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE ESTROGEN AND OR PROGESTERONE RECEPTOR-POSITIVE BREAST-CANCER - A REPORT OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(6), 1997, pp. 2302-2311